PLx Pharma Winddown Corp. Cash and Restricted Cash
PLx Pharma Winddown Corp. had Cash and Restricted Cash of $52.50 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-05-13
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $52.50M.
- 2021-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $69.40M; Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed $82.60M.
- 2021-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $80.20M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.40M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2022-03-31 | $52.50M 10-Q · filed 2022-05-13 | |
| 2021-09-30 | $69.40M 10-K · filed 2022-03-11 | $82.60M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $80.20M 10-Q · filed 2021-08-06 | |
| 2020-12-31 | $22.40M 10-K · filed 2021-03-12 | |
| 2020-09-30 | $9.10M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $13.30M 10-Q · filed 2020-08-14 |